Published in Br J Cancer on June 01, 1996
Radiation dose-volume effects in the esophagus. Int J Radiat Oncol Biol Phys (2010) 1.78
Assessment of intrafraction mediastinal and hilar lymph node movement and comparison to lung tumor motion using four-dimensional CT. Int J Radiat Oncol Biol Phys (2007) 1.08
Time course from first symptom to treatment in patients with non-small cell lung cancer referred for radiotherapy: a report by the CHART Steering Committee. Thorax (1996) 1.07
Linear quadratic and tumour control probability modelling in external beam radiotherapy. J Math Biol (2008) 0.98
Breathing-synchronized delivery: a potential four-dimensional tomotherapy treatment technique. Int J Radiat Oncol Biol Phys (2007) 0.88
Concurrent administration of Docetaxel and Stealth liposomal doxorubicin with radiotherapy in non-small cell lung cancer : excellent tolerance using subcutaneous amifostine for cytoprotection. Br J Cancer (2002) 0.88
A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group. Br J Cancer (2000) 0.83
Measurement of intra-fraction displacement of the mediastinal metastatic lymph nodes using four-dimensional CT in non-small cell lung cancer. Korean J Radiol (2012) 0.81
A prospective investigation of swallowing, nutrition, and patient-rated functional impact following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer. Dysphagia (2011) 0.78
Treatment-induced mucositis: an old problem with new remedies. Br J Cancer (1998) 0.78
What is the role of radiation-chemotherapy in the radical non-surgical management of carcinoma of the oesophagus? Upper GI Cancer Working Party of the UK Medical Research Council. Br J Cancer (1998) 0.75
Randomized clinical trial on seven-day-per-week continuous accelerated irradiation for patients with esophageal carcinoma: preliminary report on tumor response and acute toxicity. World J Gastroenterol (2006) 0.75
Management of lung cancer. Qual Health Care (1998) 0.75
The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol (1989) 5.78
TRANSIENT RADIATION MYELOPATHY (WITH REFERENCE TO LHERMITTE'S SIGN OF ELECTRICAL PARAESTHESIA). Br J Radiol (1964) 3.71
Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol (1992) 3.30
A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry (1985) 2.72
Studies of dose-fractionation on early and late responses in pig skin: a reappraisal of the importance of the overall treatment time and its effects on radiosensitization and incomplete repair. Int J Radiat Oncol Biol Phys (1991) 2.06
Relation between the pathological nature and the growth rate of human tumors. Eur J Cancer (1971) 1.92
Experience with CHART. Int J Radiat Oncol Biol Phys (1991) 1.70
Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br J Cancer (1992) 1.24
Biological basis of radiation therapy for cancer. Lancet (1992) 0.95
Radiotherapy with thrice-a-day fractionation in a short overall time: clinical experiences. Int J Radiat Oncol Biol Phys (1981) 0.87
Is control of the primary tumour worthwhile in non-oat cell carcinoma of the bronchus? Clin Oncol (R Coll Radiol) (1991) 0.84
Continuous, hyperfractionated, accelerated radiotherapy (CHART) (by Dische and Saunders) Radiother Oncol (1989) 0.83
Accelerated fractionation in advanced head and neck cancer: results and analysis of late sequelae. Radiother Oncol (1990) 0.83
Regaud Lecture, Malmö, 1992. The clinical science of radiation oncology. Radiother Oncol (1993) 0.82
Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (1992) 16.31
Meta-analysis of the literature or of individual patient data: is there a difference? Lancet (1993) 6.16
Quantitative procedures for use with the Edman-Begg sequenator. Partial sequences of two unusual immunoglobulin light chains, Rzf and Sac. Biochemistry (1971) 6.10
Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses. Br J Cancer (1977) 5.58
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. Clin Pharmacol Ther (2008) 4.54
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol (1988) 4.35
Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet (1980) 4.21
Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA (2001) 3.90
Randomised trial of personalised computer based information for cancer patients. BMJ (1999) 3.82
Clinical testing of the radiosensitiser Ro-07-0582. I. Dose tolerance, serum and tumour concentrations. Clin Radiol (1976) 3.55
Combined management of malignant teratoma of the testis. Lancet (1979) 3.12
Effect of pregnancy on prognosis for young women with breast cancer. Lancet (1994) 2.92
Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours. Clin Radiol (1976) 2.49
Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee. Radiother Oncol (1999) 2.43
Serum concentration measurements in man of the radiosensitizer Ro-07-0582: some preliminary results. Br J Cancer (1975) 2.39
Inherited deficiency of the second component of complement. Rheumatic disease associations. J Clin Invest (1976) 2.38
A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol (1997) 2.35
The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human. Drug Metab Dispos (2003) 2.32
Effects of I.C.I. 50172 in man during erect exercise. Br Med J (1968) 2.22
The hyperbaric oxygen chamber in the radiotherapy of carcinoma of the bladder. Br J Radiol (1973) 2.15
Randomised consent designs in cancer clinical trials. Eur J Cancer (1995) 2.07
The informative process in private medical consultations: a preliminary investigation. Soc Sci Med (1978) 2.03
The place of bone-marrow transplantation in acute myelogenous leukaemia. Lancet (1980) 2.03
Clinical significance of positive inotropic action of digoxin in patients with left ventricular disease. Br Heart J (1973) 2.02
Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup. J Natl Cancer Inst (2000) 1.99
Orchiectomy alone for Stage I testicular non-seminoma. A progress report on the Royal Marsden Hospital study. Br J Urol (1983) 1.87
The interpretation of marker protein assays: a critical appraisal in clinical studies and a xenograft model. Br J Cancer Suppl (1980) 1.85
The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP). Br J Cancer (1983) 1.84
The right ventricular infundibulum: has it a role? Eur J Echocardiogr (2003) 1.81
Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia (2000) 1.80
Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer (1988) 1.77
The 'rapid filling wave' of the apex cardiogram. Its relation to echocardiographic and cineangiographic measurements of ventricular filling. Br Heart J (1975) 1.75
Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol (2001) 1.75
Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax (2009) 1.74
Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J Biol Chem (1989) 1.72
Relation of isovolumic relaxation to left ventricular wall movement in man. Br Heart J (1979) 1.71
Experience with CHART. Int J Radiat Oncol Biol Phys (1991) 1.70
Clinical testing of the radiosensitiser Ro-07-0582. II. Radiosensitisation of normal and hypoxic skin. Clin Radiol (1976) 1.67
Is double data entry necessary? The CHART trials. CHART Steering Committee. Continuous, Hyperfractionated, Accelerated Radiotherapy. Control Clin Trials (1994) 1.64
Cigarette smoking and cancer of bladder and lung. Br Med J (1976) 1.63
The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. J Urol (1996) 1.63
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia (2010) 1.60
Multi-modality megatherapy with [131I]meta-iodobenzylguanidine, high dose melphalan and total body irradiation with bone marrow rescue: feasibility study of a new strategy for advanced neuroblastoma. Eur J Cancer (1995) 1.58
Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours. Lancet (1982) 1.58
Hyperbaric oxygen and radiotherapy: a Medical Research Council trial in carcinoma of the cervix. Br J Radiol (1978) 1.57
X-ray structure of the major adduct of the anticancer drug cisplatin with DNA: cis-[Pt(NH3)2(d(pGpG))]. Science (1985) 1.57
Rheumatology education in the late 20th century. Br J Rheumatol (1989) 1.54
The RAGE litigation. Radiation Action Group Exposure. Lancet (1998) 1.54
The chronicity of symptoms and disability in Reiter's syndrome. An analysis of 131 consecutive patients. Ann Intern Med (1979) 1.53
Oxygen uptake kinetics during two bouts of heavy cycling separated by fatiguing sprint exercise in humans. J Appl Physiol (1985) (2002) 1.53
Comparison of laryngeal mask and intubating laryngeal mask insertion by the naïve intubator. Br J Anaesth (2000) 1.52
Evidence for two types of spatial representations: hemispheric specialization for categorical and coordinate relations. J Exp Psychol Hum Percept Perform (1989) 1.51
Behavioral, attitudinal, and physiologic characteristics of smoking and nonsmoking asbestos-exposed shipyard workers. J Occup Med (1983) 1.50
Multifocal synchronous osteosarcoma: the Scottish Bone Tumour Registry experience. Med Pediatr Oncol (1993) 1.50
Childhood nocturnal enuresis: factors associated with outcome of treatment with an enuresis alarm. Dev Med Child Neurol (1983) 1.48
The use of beta-adrenergic receptor blocking drugs in dysrhythmias. Prog Cardiovasc Dis (1969) 1.47
Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors. Br J Urol (1981) 1.46
Re-audit of radiotherapy waiting times 2003. Clin Oncol (R Coll Radiol) (2004) 1.45
Childhood enuresis. A family problem. Practitioner (1978) 1.43
Parotid gland function following accelerated and conventionally fractionated radiotherapy. Radiother Oncol (1991) 1.43
Management of enuresis. Br Med J (1971) 1.43
Genetic polymorphism of mouse immunoglobulin light chains revealed by isoelectric focusing. J Exp Med (1976) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Misonidazole-a drug for trial in radiotherapy and oncology. Int J Radiat Oncol Biol Phys (1979) 1.41
Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials. Br J Cancer (1995) 1.41
Complications of varicose vein surgery. Ann R Coll Surg Engl (1997) 1.39
Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). Br Med J (Clin Res Ed) (1988) 1.39
Peer consultation: a look at process. Clin Nurse Spec (1995) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum. Br J Cancer Suppl (1978) 1.38
Tomlinson report. BMJ (1993) 1.38
Thirty years of Medical Research Council randomized trials in solid tumours. Clin Oncol (R Coll Radiol) (1997) 1.38
Hands-on robotic unicompartmental knee replacement: a prospective, randomised controlled study of the acrobot system. J Bone Joint Surg Br (2006) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Cross sectional survey of patients' satisfaction with information about cancer. BMJ (1999) 1.33
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Quality of life assessment in clinical trials--guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience. MRC Cancer Trials Office. Eur J Cancer (1997) 1.32
Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia. Lancet (1983) 1.31
Three decades of health care use by the elderly, 1965-1998. Health Aff (Millwood) (2001) 1.30
Self-reported sleep and mood disturbance in chronic pain patients. Clin J Pain (1998) 1.29
Who gets radiotherapy? Health Trends (1990) 1.28
Continuous wave Doppler echocardiography and coarctation of the aorta: gradients and flow patterns in the assessment of severity. Br Heart J (1990) 1.27
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Pharmacokinetics of nicotinamide and its effect on blood pressure, pulse and body temperature in normal human volunteers. Radiother Oncol (1992) 1.27
The hyperbaric oxygen chamber in the radiotherapy of carcinoma of the uterine cervix. Br J Radiol (1974) 1.26
Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br J Cancer (1992) 1.24
Carcinoma of the cervix--anaemia, radiotherapy and hyperbaric oxygen. Br J Radiol (1983) 1.23
Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies. Cancer (1989) 1.21
Tutorial in biostatistics Bayesian data monitoring in clinical trials. Stat Med (1997) 1.21